SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-23-006050
Filing Date
2023-04-17
Accepted
2023-04-17 16:05:36
Documents
20

Document Format Files

Seq Description Document Type Size
1 DEF 14A chrs-20230607xdef14a.htm   iXBRL DEF 14A 1081749
2 GRAPHIC chrs-20230607xdef14a_a001.jpg GRAPHIC 4934
3 GRAPHIC chrs-20230607xdef14a_a003.jpg GRAPHIC 41756
4 GRAPHIC chrs-20230607xdef14a_a004.jpg GRAPHIC 38841
5 GRAPHIC chrs-20230607xdef14a_a005.jpg GRAPHIC 41596
6 GRAPHIC chrs-20230607xdef14a_bg001.jpg GRAPHIC 121640
7 GRAPHIC chrs-20230607xdef14a_bg002.jpg GRAPHIC 105085
  Complete submission text file 0001558370-23-006050.txt   2627762

Data Files

Seq Description Document Type Size
8 EX-101.SCH chrs-20230607.xsd EX-101.SCH 5373
9 EX-101.DEF chrs-20230607_def.xml EX-101.DEF 6552
10 EX-101.LAB chrs-20230607_lab.xml EX-101.LAB 12710
11 EX-101.PRE chrs-20230607_pre.xml EX-101.PRE 6483
14 EXTRACTED XBRL INSTANCE DOCUMENT chrs-20230607xdef14a_htm.xml XML 203542
Mailing Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065
Business Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065 (650) 649-3530
Coherus BioSciences, Inc. (Filer) CIK: 0001512762 (see all company filings)

IRS No.: 273615821 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36721 | Film No.: 23823984
SIC: 2836 Biological Products, (No Diagnostic Substances)